These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 23047013)

  • 1. Prophylactic, therapeutic and neutralizing effects of zinc oxide tetrapod structures against herpes simplex virus type-2 infection.
    Antoine TE; Mishra YK; Trigilio J; Tiwari V; Adelung R; Shukla D
    Antiviral Res; 2012 Dec; 96(3):363-75. PubMed ID: 23047013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virostatic potential of micro-nano filopodia-like ZnO structures against herpes simplex virus-1.
    Mishra YK; Adelung R; Röhl C; Shukla D; Spors F; Tiwari V
    Antiviral Res; 2011 Nov; 92(2):305-12. PubMed ID: 21893101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-heparan sulfate peptides that block herpes simplex virus infection in vivo.
    Tiwari V; Liu J; Valyi-Nagy T; Shukla D
    J Biol Chem; 2011 Jul; 286(28):25406-15. PubMed ID: 21596749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc oxide tetrapods inhibit herpes simplex virus infection of cultured corneas.
    Duggal N; Jaishankar D; Yadavalli T; Hadigal S; Mishra YK; Adelung R; Shukla D
    Mol Vis; 2017; 23():26-38. PubMed ID: 28275313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of herpes simplex type 1 and type 2 infections by Oximacro(®), a cranberry extract with a high content of A-type proanthocyanidins (PACs-A).
    Terlizzi ME; Occhipinti A; Luganini A; Maffei ME; Gribaudo G
    Antiviral Res; 2016 Aug; 132():154-64. PubMed ID: 27321663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Steps in Herpes Simplex Virus Infection Blocked by a Proteasome Inhibitor.
    Schneider SM; Pritchard SM; Wudiri GA; Trammell CE; Nicola AV
    mBio; 2019 May; 10(3):. PubMed ID: 31088925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel glycoprotein D-specific monoclonal antibody neutralizes herpes simplex virus.
    Du R; Wang L; Xu H; Wang Z; Zhang T; Wang M; Ning Y; Deng F; Hu Z; Wang H; Li Y
    Antiviral Res; 2017 Nov; 147():131-141. PubMed ID: 29061442
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HVEM and nectin-1 are the major mediators of herpes simplex virus 1 (HSV-1) entry into human conjunctival epithelium.
    Akhtar J; Tiwari V; Oh MJ; Kovacs M; Jani A; Kovacs SK; Valyi-Nagy T; Shukla D
    Invest Ophthalmol Vis Sci; 2008 Sep; 49(9):4026-35. PubMed ID: 18502984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiviral Effects of ABMA against Herpes Simplex Virus Type 2 In Vitro and In Vivo.
    Dai W; Wu Y; Bi J; Wang S; Li F; Kong W; Barbier J; Cintrat JC; Gao F; Gillet D; Su W; Jiang C
    Viruses; 2018 Mar; 10(3):. PubMed ID: 29522484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral effect of Chinese herbal prescription JieZe-1 on adhesion and penetration of VK2/E6E7 with herpes simplex viruses type 2.
    Duan Q; Liu T; Yuan P; Huang C; Shao Q; Xu L; Sun J; Huang G; Chen Z
    J Ethnopharmacol; 2020 Mar; 249():112405. PubMed ID: 31743766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion.
    Hubbard S; Choudhary S; Maus E; Shukla D; Swenson S; Markland FS; Tiwari V
    Antivir Ther; 2012; 17(7):1319-26. PubMed ID: 22875654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between herpesvirus entry mediator and HSV-2 glycoproteins mediates HIV-1 entry of HSV-2-infected epithelial cells.
    Hu K; He S; Xiao J; Li M; Luo S; Zhang M; Hu Q
    J Gen Virol; 2017 Sep; 98(9):2351-2361. PubMed ID: 28809154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Griffithsin and Carrageenan Combination To Target Herpes Simplex Virus 2 and Human Papillomavirus.
    Levendosky K; Mizenina O; Martinelli E; Jean-Pierre N; Kizima L; Rodriguez A; Kleinbeck K; Bonnaire T; Robbiani M; Zydowsky TM; O'Keefe BR; Fernández-Romero JA
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7290-8. PubMed ID: 26369967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthetic analogues of bovine bactenecin dodecapeptide reduce herpes simplex virus type 2 infectivity in mice.
    Shestakov A; Jenssen H; Hancock RE; Nordström I; Eriksson K
    Antiviral Res; 2013 Nov; 100(2):455-9. PubMed ID: 24012999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhancement of antiviral activity of human alpha-defensin 5 against herpes simplex virus 2 by arginine mutagenesis at adaptive evolution sites.
    Wang A; Chen F; Wang Y; Shen M; Xu Y; Hu J; Wang S; Geng F; Wang C; Ran X; Su Y; Cheng T; Wang J
    J Virol; 2013 Mar; 87(5):2835-45. PubMed ID: 23269800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
    Ceña-Diez R; Vacas-Córdoba E; García-Broncano P; de la Mata FJ; Gómez R; Maly M; Muñoz-Fernández MÁ
    Int J Nanomedicine; 2016; 11():2147-62. PubMed ID: 27274240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycoprotein B plays a predominant role in mediating herpes simplex virus type 2 attachment and is required for entry and cell-to-cell spread.
    Cheshenko N; Herold BC
    J Gen Virol; 2002 Sep; 83(Pt 9):2247-2255. PubMed ID: 12185280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of dual sites of action of dendrimers: SPL-2999 inhibits both virus entry and late stages of herpes simplex virus replication.
    Gong Y; Matthews B; Cheung D; Tam T; Gadawski I; Leung D; Holan G; Raff J; Sacks S
    Antiviral Res; 2002 Aug; 55(2):319-29. PubMed ID: 12103432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A sugar binding protein cyanovirin-N blocks herpes simplex virus type-1 entry and cell fusion.
    Tiwari V; Shukla SY; Shukla D
    Antiviral Res; 2009 Oct; 84(1):67-75. PubMed ID: 19665490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.